Counselling of the Prostate Cancer Patient as a Whole Person

Slides:



Advertisements
Similar presentations
Medical Management for BPH: The Role of Combination Therapy
Advertisements

Pascal Rischmann  European Urology Supplements 
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Prostate Cancer 2008: Challenges in Diagnosis and Management
Prostate Cancer: Highlights from 2006
Management of Acute and Chronic Retention in Men
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Prostate Cancer Epidemic in Sight?
Bladder Cancer: A Major Public Health Issue
What is New in Bladder Cancer Diagnosis and Management?
Back to the Future: Introduction and Conclusions
What is New in Hormone Therapy for Prostate Cancer in 2007?
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Prostate Cancer Detection: A View of the Future
Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening?  Bob Djavan  European.
Counselling the Prostate Cancer Patient
Laurent Boccon-Gibod  European Urology Supplements 
Prostate Cancer Epidemic in Sight?
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
Richard C. Harkaway  European Urology Supplements 
Volume 50, Issue 5, Pages (November 2006)
Optimising Hormone Therapy in Advanced Disease
Tim Schneider  European Urology Supplements 
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
The Importance of Testosterone Control in Prostate Cancer
Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis
Jacques Irani  European Urology Supplements 
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Neal Shore  European Urology Supplements 
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Long-Term Hormonal Therapy: Who Would Benefit?
The Hallmarks of BPH Progression and Risk Factors
Sergio Bracarda  European Urology Supplements 
Pharmacotherapy in Stress and Mixed Incontinence
Christian Stief  European Urology Supplements 
Bisphosphonates Can Prevent Skeletal Complications of Malignant Bone Disease from Prostate Cancer and Renal Cell Carcinoma  Fred Saad  European Urology.
New Trends in Managing the Prostate Cancer Patient
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Prostate Cancer 2008: Challenges in Diagnosis and Management
Martin Michel, Jean de la Rosette  European Urology Supplements 
Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer  P. Mongiat-Artus, P. Teillac 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
Improving Flexibility and Quality of Life for Your Patients: A Must?
The Burden of Stress Urinary Incontinence
Profile of Silodosin European Urology Supplements
New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men
Volume 17, Issue 2, Pages (February 1950)
The Increasing Responsibility of the Urologist in Maintaining Bone Health in Prostate Cancer Patients  Kurt Miller  European Urology Supplements  Volume.
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Management of Prostate Cancer: Global Strategies
Treatment Options in Prostate Cancer Once Primary Therapy Fails
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Joaquim Bellmunt  European Urology Supplements 
Classification of Mixed Incontinence
The Impact of Premature Ejaculation on Partners and Relationships
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Integrating Patient Risk Profiles in the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) in Clinical Practice 
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer  Noel W. Clarke  European Urology Supplements 
Jan Roigas  European Urology Supplements 
Michael Marberger  European Urology Supplements 
Presentation transcript:

Counselling of the Prostate Cancer Patient as a Whole Person Thierry Janssen  European Urology Supplements  Volume 7, Issue 1, Pages 29-34 (February 2008) DOI: 10.1016/j.eursup.2007.10.002 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 The triune brain consists of three different layers through which the information is processed physically (reptilian brain) (1), emotionally (paleo-mammalian brain or limbic system) (2), and intellectually (mammalian brain or neocortex) (3). European Urology Supplements 2008 7, 29-34DOI: (10.1016/j.eursup.2007.10.002) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Outcomes of voting among urologists participating in the New Horizons in Urology 2007 meeting in Monaco. Urologists were questioned concerning the time needed to announce the diagnosis of prostate cancer (PCa) to their patient and the duration of a consultation with a patient with PCa at follow-up. European Urology Supplements 2008 7, 29-34DOI: (10.1016/j.eursup.2007.10.002) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 3 Expectations of the benefits of complementary therapy (nutritional interventions) based on the outcomes of a questionnaire among >1000 men with prostate cancer (PCa). Almost all believed that complementary therapy would help them to live longer and improve their quality of life (QoL); the majority thought it would relieve symptoms and half the respondents expected it to cure the disease [23]. European Urology Supplements 2008 7, 29-34DOI: (10.1016/j.eursup.2007.10.002) Copyright © 2007 European Association of Urology Terms and Conditions